Literature DB >> 24610730

Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage.

Svitlana Garbuzova-Davis1, Edward Haller, Stephanie N Williams, Eithan D Haim, Naoki Tajiri, Diana G Hernandez-Ontiveros, Aric Frisina-Deyo, Sean M Boffeli, Paul R Sanberg, Cesario V Borlongan.   

Abstract

Stroke is a life-threatening disease leading to long-term disability in stroke survivors. Cerebral functional insufficiency in chronic stroke might be due to pathological changes in brain areas remote from the initial ischemic lesion, i.e., diaschisis. Previously, we showed that the damaged blood-brain barrier (BBB) was involved in subacute diaschisis. The present study investigated BBB competence in chronic diaschisis by using a transient middle cerebral artery occlusion (tMCAO) rat model. Our results demonstrated significant BBB damage mostly in the ipsilateral striatum and motor cortex in rats at 30 days after tMCAO. The BBB alterations were also determined in the contralateral hemisphere via ultrastructural and immunohistochemical analyses. Major BBB pathological changes in contralateral remote striatum and motor cortex areas included 1) vacuolated endothelial cells containing large autophagosomes, 2) degenerated pericytes displaying mitochondria with cristae disruption, 3) degenerated astrocytes and perivascular edema, 4) Evans blue extravasation, and 5) appearance of parenchymal astrogliosis. Discrete analyses of striatal and motor cortex areas revealed significantly higher autophagosome accumulation in capillaries of ventral striatum and astrogliosis in dorsal striatum in both cerebral hemispheres. These widespread microvascular alterations in ipsilateral and contralateral brain hemispheres suggest persistent and/or continued BBB damage in chronic ischemia. The pathological changes in remote brain areas likely indicate chronic ischemic diaschisis, which should be considered in the development of treatment strategies for stroke.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  BBB; MCAO; astrocytes; autophagosomes; chronic diaschisis; rats

Mesh:

Substances:

Year:  2014        PMID: 24610730      PMCID: PMC4107178          DOI: 10.1002/cne.23582

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  78 in total

1.  Striatal and central extended amygdala parts of the interstitial nucleus of the posterior limb of the anterior commissure: evidence from tract-tracing techniques in the rat.

Authors:  S J Shammah-Lagnado; G F Alheid; L Heimer
Journal:  J Comp Neurol       Date:  2001-10-08       Impact factor: 3.215

2.  Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats.

Authors:  Kenneth M Sicard; Nils Henninger; Marc Fisher; Timothy Q Duong; Craig F Ferris
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

Review 3.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

Review 4.  Advances in the vascular pathophysiology of ischemic stroke.

Authors:  G J del Zoppo; J M Hallenbeck
Journal:  Thromb Res       Date:  2000-05-01       Impact factor: 3.944

5.  The role of diaschisis in stroke recovery.

Authors:  R J Seitz; N P Azari; U Knorr; F Binkofski; H Herzog; H J Freund
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

6.  Evidence for transhemispheric diaschisis in unilateral stroke.

Authors:  J A Dobkin; R L Levine; H L Lagreze; D A Dulli; R J Nickles; B R Rowe
Journal:  Arch Neurol       Date:  1989-12

7.  Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion.

Authors:  H Nagasawa; K Kogure
Journal:  Stroke       Date:  1989-08       Impact factor: 7.914

8.  Autophagy in hypoxia-ischemia induced brain injury: evidence and speculations.

Authors:  Walter Balduini; Silvia Carloni; Giuseppe Buonocore
Journal:  Autophagy       Date:  2009-02-07       Impact factor: 16.016

9.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

10.  Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Deborah Tepper; Aidan Leonard
Journal:  Front Neurol       Date:  2013-04-03       Impact factor: 4.003

View more
  29 in total

1.  Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Toward Blood-Brain Barrier Repair in Ischemic Stroke Rats.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Roger Lin; Cesario V Borlongan
Journal:  Stem Cells       Date:  2017-03-10       Impact factor: 6.277

2.  Scheme of Ischaemia-triggered Agents during Brain Infarct Evolution in a Rat Model of Permanent Focal Ischaemia.

Authors:  Petra Bonova; Viera Danielisova; Miroslava Nemethova; Milina Matiasova; Martin Bona; Miroslav Gottlieb
Journal:  J Mol Neurosci       Date:  2015-05-14       Impact factor: 3.444

3.  CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Authors:  Mustafa Balkaya; Il-Doo Kim; Faariah Shakil; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-13       Impact factor: 6.200

4.  Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie Navarro; Tony E Besong; Kayla J Boccio; Surafuale Hailu; Mohammed Khatib; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Exp Neurol       Date:  2018-08-30       Impact factor: 5.330

5.  Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.

Authors:  Noëmie Jean LeBlanc; Romain Menet; Katherine Picard; Geneviève Parent; Marie-Ève Tremblay; Ayman ElAli
Journal:  Mol Neurobiol       Date:  2019-03-09       Impact factor: 5.590

Review 6.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

7.  Cell-specific activation of RIPK1 and MLKL after intracerebral hemorrhage in mice.

Authors:  Sevda Lule; Limin Wu; Aliyah Sarro-Schwartz; William J Edmiston; Saef Izzy; Tanya Songtachalert; So Hee Ahn; Neil D Fernandes; Gina Jin; Joon Yong Chung; Siddharth Balachandran; Eng H Lo; David Kaplan; Alexei Degterev; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-19       Impact factor: 6.200

8.  Reperfusion facilitates reversible disruption of the human blood-brain barrier following acute ischaemic stroke.

Authors:  Chang Liu; Sheng Zhang; Shenqiang Yan; Ruiting Zhang; Feina Shi; Xinfa Ding; Mark Parsons; Min Lou
Journal:  Eur Radiol       Date:  2017-08-30       Impact factor: 5.315

9.  Chronic global analysis of vascular permeability and cerebral blood flow after bone marrow stromal cell treatment of traumatic brain injury in the rat: A long-term MRI study.

Authors:  Lian Li; Michael Chopp; Guangliang Ding; Qingjiang Li; Asim Mahmood; Quan Jiang
Journal:  Brain Res       Date:  2017-09-09       Impact factor: 3.252

10.  Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Naoki Tajiri; Avery Thomson; Jennifer Barretta; Stephanie N Williams; Eithan D Haim; Hua Qin; Aric Frisina-Deyo; Jerry V Abraham; Paul R Sanberg; Harry Van Loveren; Cesario V Borlongan
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.